Friday, 19th April 2019
Cell Biology and Immunology

Regulation and function of proinflammatory mediators and their involvement in immune                            and inflammatory mediated diseases

 

 

 

 Grupo-400

 


 

 

Manuel Fresno

 

 ASciStaff

 

APublications

 

 

 

 

Research summary:

A010m.fresno.image01.300px
Atheroma formation is increased in mice  with a selective Cox-2 deficiency .  Irradiated ApoE-/- mice were reconstituted with Bone Marrow from Wild type (WT) or Cox-2 -/-  mice. 12 weeks after being on a high-fat-diet, arteries were analyzed.
A010m.fresno.image02.300px
Arginase I and CD68 expression in BALB/c mice heart tissue during acute T. cruzi infection. Tissue sections obtained from hearts of infected BALB/c mice analysed by immunofluorescence confocal microscopy. Boxed regions are shown at two-fold magnification of original (x400) in insets.

Inflammation underlies many of the most prevalent diseases of the developed countries, as Cardiovascular diseases, Obesity and Cancer. We focused on molecular mechanisms of inflammation and induction and activity of inflammatory mediators. We demonstrated the early induction of Cox-2 in T lymphocytes after TCR triggering, having this molecule important functional effects on T cell activity and demonstrated the crucial role of NFAT/Cox-2 in endothelial and colon carcinoma cells. We also demonstrated that c-rel activity can be modulated through phosphorylation, subsequently extended to NFAT, defining a new signal transduction pathway involving NIK, Cot and PK- Cz  kinases.

There are similarities between recognition of pathogens by TLR, the immune response induced for infection and chronic inflammation.Our current work is based in the involvement of TLR/NIK/c-rel-NFAT/Cox-2/prostaglandins (PGs) in novel functions of the immune system and in inflammatory pathologies as Atherosclerosis, Obesity Cancer and GVHD. We are using a multidisciplinary approach (Cell and Molecular Biology, Immunology and integrated imaging techniques) and murine models of disease. We are analyzing the regulation and function of TLR/NIK/c-rel-NFAT/Cox-2/PGs in various tissues and cell types and addressing the cellular interactions and the signal transduction pathways triggered by PGs, chemokines and cytokines and their mutual influence in various cell types and in animal models.

We have started to unravel the link between TLRs and some of their signaling pathways that activate c-rel and NFAT. Moreover, c-rel and NFAT through the control of some important mediators of the inflammatory cascade, as Cox-2, increase inflammatory responses. Besides, PGs trigger migration of immune cells and affect the cardiovascular system, adipogenesis and cancer. We have also found that TLR2/NFAT axis controls the expression of some adipogenic genes and repressed the antiadipogenic ones.

On the other hand, Trypanosoma cruzi, the agent of Chagas’disease, is a heterogeneous complex of organisms. Genetic lineages have been defined, however, understanding of their comparative biology and public health importance is fragmentary. Besides, the underlying cause of the pathogenesis of this disease (autoimmunity vs parasite mediated inflammation) is controversial.  We have contributed in the past, to define the protective immune mechanism and recently to the double-edge role of NO and myeloid derived suppressor cells (MDSC) and other immunopathogenic mechanisms. Our current focus is to continue the elucidation of  the pathogenic mechanism underlying T. cruzi infection (and by extension to other related infections) specially the contribution of Th17, Tregs or MDSC responses and autoimmunity as well as the pathogenetic differences between genetic lineages of T. cruzi. Besides, we are studying how the parasite enters, infects and escapes destruction by myeloid cells. All intended for improved understanding and prevention of Chagas’disease.  


 

Publications:

  • Aquilino, C., Gonzalez Rubio, M.L., Seco, E.M., Escudero, L., Corvo, L., Soto, M., Fresno, M., Malpartida, F., and Bonay, P. (2012). Differential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineage. PLoS One 7, e40901.
  • Calderon, J., Maganto-Garcia, E., Punzon, C., Carrion, J., Terhorst, C., and Fresno, M. (2012). The Receptor Slamf1 on the Surface of Myeloid Lineage Cells Controls Susceptibility to Infection by Trypanosoma cruzi. PLoS Pathog. 8, e1002799.
  • Calvo-Alvarez, E., Guerrero, N.A., Alvarez-Velilla, R., Prada, C.F., Requena, J.M., Punzon, C., Llamas, M.A., Arevalo, F.J., Rivas, L., Fresno, M., Perez-Pertejo, Y., Balana-Fouce, R., and Reguera, R.M. (2012). Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis. PLoS Negl. Trop. Dis. 6, e1927.
  • De La Fuente, H., Perez-Gala, S., Bonay, P., Cruz-Adalia, A., Cibrian, D., Sanchez-Cuellar, S., Dauden, E., Fresno, M., Garcia-Diez, A., and Sanchez-Madrid, F. (2012). Psoriasis in humans is associated with down-regulation of galectins in dendritic cells. J. Pathol. 228, 193-203.
  • Diaz-Munoz, M.D., Osma-Garcia, I.C., Fresno, M., and Iniguez, M.A. (2012). Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Biochem. J. 443, 451-461.

 

Other activities:


Socio Honorario Sociedad Cubana de Inmunología. Mayo, 2012.


 

Patents:

Sánchez López, José Mª, Martínez Insua, Marta, Romero Millán, Francisco, FERNÁNDEZ-MEDARDE, Antonio, FERNÁNDEZ CHIMENO, Rosa Isabel, FRESNO ESCUDERO, Manuel, SÁNCHEZ VALDEPEÑAS, María del Carmen, RAMÍREZ ORELLANA, Manuel. HEXACYCLIC POLYKETIDES AS KINASE INHIBITORS. N. de solicitud: PCT/EP2011/062379 Fecha de prioridad: 19.07.2011 Entidad titular: INSTITUTO BIOMAR, S.A. Empresa/s que la están explotando: INSTITUTO BIOMAR, S.A.


 

Doctoral theses:

Vinatha Sreeramjumar (2011). Role of Prostaglandin E2 in T cell activation and migration. Universidad Autónoma de Madrid. Convenio de Cotuela UAM-Universidad de San Raffelle (Roma, Italia). Director: Manuel Fresno. Co-directores: Dr. Federico Mayor Menéndez y Dra. Natalia Cuesta.

Jossela Calderón Deago (2011). Implicación del receptor SLAM (CD150) en la infección por Trypanosoma cruzi.Universidad Autónoma de Madrid. Director: Manuel Fresno.

Inés Claire García Osma (2012). Prostaglandinas dependientes de ciclooxigenasa-2<: Moléculas clave en el conrol funcional de los macrófagos. Universidad Autónoma de Madrid. Director: Manuel Fresno.

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

COOKIES POLICY

What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: